It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Mapping protein–protein interactions is an invaluable tool for understanding protein function. Here, we report the first large-scale study of protein–protein interactions in human cells using a mass spectrometry-based approach. The study maps protein interactions for 338 bait proteins that were selected based on known or suspected disease and functional associations. Large-scale immunoprecipitation of Flag-tagged versions of these proteins followed by LC-ESI-MS/MS analysis resulted in the identification of 24 540 potential protein interactions. False positives and redundant hits were filtered out using empirical criteria and a calculated interaction confidence score, producing a data set of 6463 interactions between 2235 distinct proteins. This data set was further cross-validated using previously published and predicted human protein interactions. In-depth mining of the data set shows that it represents a valuable source of novel protein–protein interactions with relevance to human diseases. In addition, via our preliminary analysis, we report many novel protein interactions and pathway associations.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
1 Protana (now Transition Therapeutics), Toronto, Ontario, Canada; Infochromics, MaRS Discovery District, Toronto, Ontario, Canada
2 Protana (now Transition Therapeutics), Toronto, Ontario, Canada
3 Faculty of Medicine, The Ottawa Institute of Systems Biology, University of Ottawa, BMI, Ottawa, Ontario, Canada
4 Protana (now Transition Therapeutics), Toronto, Ontario, Canada; Information Engineering Center, Department of Mechanical and Industrial Engineering, University of Toronto, Toronto, Ontario, Canada
5 Protana (now Transition Therapeutics), Toronto, Ontario, Canada; Faculty of Medicine, The Ottawa Institute of Systems Biology, University of Ottawa, BMI, Ottawa, Ontario, Canada